ArticleDermatology and therapy2024

Real-World Long-Term Effectiveness of Risankizumab Among Patients with Moderate-to-Severe Psoriasis: Analysis from an International Medical Chart Review (RAPID) Study.

Andreas Pinter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.